Proteomics

Dataset Information

0

Rational in vitro design of a two-phage cocktail against a contemporary Acinetobacter baumannii strain recovered from a burned patient at CHUV


ABSTRACT: Acinetobacter baumannii is currently a major threat to human health. With the spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, the development of complementary strategies is needed. A promising complimentary and realistic strategy could be phage therapy, which uses bacteriophages (phages), i.e viruses that specifically infect and kill bacterial cells during their life cycle. We designed a two-phage cocktail highly efficient against an extensive drug-resistant (XDR) A. baumannii isolate collected from a patient with burn wound infection at CHUV (termed Ab125). A first in vitro screen of our collection of 34 different phages identified only phage vB_AbaM_3098 as capable of lysing Ab125. However, quick selection of phage-resistant clones (termed Ab139) occurred. Comparative genomics and proteomics between Ab125 and Ab139 revealed several key variations. Very interestingly, we observed that Ab139 became susceptible to six different phages in the collection, otherwise inactive on Ab125. Phage-resistance was also selected when Ab139 was challenged with either of the six phages, with bacterial regrowth observed between 14 h and 16 h. However, combination of vB_AbaM_3098 and vB_AbaM_3014 led to a two-phage cocktail capable of totally inhibiting the growth of Ab125. Treatment with the phage cocktail led to 90% survival after 5 days in the in vivo Galleria Mellonella model of infectious diseases, compared to 0% in the non-treated group. We show that the combination of a phage that only slightly shifted the in vitro bacterial growth curve with an “inactive phage” led to the formulation of a highly bactericidal phage cocktail against Ab125. We then tested the therapeutic potential of the assembled cocktail in synergy with antibiotics and found a synergy with colistin. This work highlights the complexity sometimes involved in the assembly of potent phage cocktail.

INSTRUMENT(S):

ORGANISM(S): Acinetobacter Baumannii (strain Atcc 17978 / Cip 53.77 / Lmg 1025 / Ncdc Kc755 / 5377)

SUBMITTER: Hugues de Villiers de la Noue  

LAB HEAD: Grégory Resch

PROVIDER: PXD062593 | Pride | 2025-12-08

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications

Rational Design of a Potent Two-Phage Cocktail Against a Contemporary <i>Acinetobacter baumannii</i> Strain Recovered from a Burned Patient at the Lausanne University Hospital.

de Villiers de la Noue Hugues H   Golliard Gwenaëlle G   Vuattoux Xavier X   Resch Grégory G  

Viruses 20251029 11


<i>Acinetobacter baumannii</i> is a critical public health threat, particularly with the rise in multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains that limit treatment options. Phage therapy, which uses bacteriophages to target bacteria, offers a promising alternative. We isolated an XDR strain (Ab125) from a burn wound infection and screened 34 phages, identifying vB_AbaM_3098 as the only effective candidate. However, resistance rapidly emerged, producing a derivative strai  ...[more]

Similar Datasets

2024-07-17 | GSE271537 | GEO
2024-02-19 | GSE255619 | GEO
2015-09-11 | E-GEOD-72885 | biostudies-arrayexpress
2024-10-01 | GSE272297 | GEO
2015-09-11 | GSE72885 | GEO
2025-10-01 | GSE308794 | GEO
2023-06-21 | GSE202972 | GEO
2025-02-05 | PXD054755 | Pride
2025-07-31 | GSE302131 | GEO
2019-01-29 | PXD011263 | Pride